New hope for surgery patients: a stronger, Longer-Lasting Anti-Nausea drug
NCT ID NCT06981754
Summary
This study is testing a new version of a common anti-nausea drug called dexamethasone palmitate. Researchers want to see if it works better and is safer than the standard drug at preventing nausea and vomiting in the first 24 hours after minimally invasive surgery. The trial will involve 588 adults having planned laparoscopic or thoracoscopic surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE NAUSEA AND VOMITING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Tiantan Hospital
RECRUITINGBeijing, Beijing Municipality, 100070, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.